Fewer platelets could be used for some cancer and bone-marrow transplantation patients

Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Centre and 28 other medical institutions...

Read the whole article on

More from